Ascendis Pharma A/S
- Stock Issuer and Owners
| Due Diligence for Asset Managers |
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
|
| Ascendis Pharma A/S |
| Ticker | ASND |
| CIK # | 0001612042 |
| CUSIP | 04351P101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | Tuborg Boulevard 5, Hellerup, DK-2900 |
| Source |
[EDGAR]
|
| Reg D Offering (Form D) |
Filed |
Raised |
Terms |
| Ascendis Pharma A/S |
2014-12-09 |
60.0 M |
Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
|
| 13F Ownership Over Time | Holders | Shares Held |
| 2026-03-31 |
273 |
56,049,073 |
| 2025-12-31 |
308 |
62,216,636 |
| 2025-09-30 |
290 |
59,899,502 |
| 2025-06-30 |
252 |
57,008,779 |
| 2025-03-31 |
247 |
59,415,305 |
| 2024-12-31 |
218 |
58,167,692 |
| 2024-09-30 |
222 |
58,457,278 |
| 2024-06-30 |
204 |
58,673,893 |
| 2024-03-31 |
192 |
56,527,882 |
| 2023-12-31 |
189 |
54,875,247 |
| 2023-09-30 |
166 |
54,553,361 |
| 2023-06-30 |
166 |
55,247,868 |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 217617589, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 3, "random_n": 1.9491740397207116}
False
326345380